We are live on ! Find out more
HURA

TuHURA Biosciences
HURA

21 hedge funds and large institutions have $3.95M invested in TuHURA Biosciences in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

486% more capital invested

Capital invested by funds: $674K → $3.95M (+$3.28M)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

40% more funds holding

Funds holding: 15 → 21 (+6)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
21
Holders Change
+6
Holders Change %
+40%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
6
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$1.22M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.05M
3
S
swisspartners
Liechtenstein
+$533K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$295K
5
Citadel Advisors
Citadel Advisors
Florida
+$149K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$22K
2
Squarepoint
Squarepoint
New York
-$15K
3
GSEP
Golden State Equity Partners
California
-$14K
4
TRCT
Tower Research Capital (TRC)
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$1.57M +$1.22M +360 +231%
Vanguard Group
2
Vanguard Group
Pennsylvania
$975K +$1.05M +309 +2,809%
S
3
swisspartners
Liechtenstein
$479K +$533K +157 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$264K +$295K +87 New
Citadel Advisors
5
Citadel Advisors
Florida
$134K +$149K +44 New
Renaissance Technologies
6
Renaissance Technologies
New York
$81K +$13.6K +4 +17%
Northern Trust
7
Northern Trust
Illinois
$77K +$40.8K +12 +92%
VF
8
Virtu Financial
New York
$73K +$47.5K +14 +140%
RE
9
RBC Europe
United Kingdom
$65.5K – – –
ECM
10
Evergreen Capital Management
Washington
$43K – – –
APA
11
Allegiant Private Advisors
Florida
$31K – – –
Envestnet Asset Management
12
Envestnet Asset Management
Illinois
$27K +$30.6K +9 New
RJA
13
Raymond James & Associates
Florida
$27K +$30.6K +9 New
State Street
14
State Street
Massachusetts
$24K – – –
TSS
15
Two Sigma Securities
New York
$21K +$23.8K +7 New
FNB
16
Farmers National Bank
Kentucky
$19.6K – – –
Morgan Stanley
17
Morgan Stanley
New York
$10K +$10.2K +3 New
SFS
18
Sowell Financial Services
Arkansas
$10K +$17K +5 New
UBS Group
19
UBS Group
Switzerland
$8K +$10.2K +3 New
LC
20
Lindbrook Capital
California
$7K +$3.4K +1 +100%
Osaic Holdings
21
Osaic Holdings
Arizona
$5K +$6.79K +2 New
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$1K – – –
Two Sigma Investments
23
Two Sigma Investments
New York
– -$22K -10 Closed
Squarepoint
24
Squarepoint
New York
– -$15K -7 Closed
GSEP
25
Golden State Equity Partners
California
– -$14K -6 Closed
1
2

HURA Hedge Fund Activity: Q1 2021 in Review

21 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q1 2021, worth a combined $3.95M — up 486% from $674K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new HURA positions and 4 closed out — a net gain of 6 holders — while 6 added to existing stakes and 0 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.22M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $22K sold.

  • 21 institutional investors held TuHURA Biosciences (HURA) as of Q1 2021, up from 15 in Q4 2020.
  • Funds reported $3.95M of TuHURA Biosciences stock for Q1 2021, up 486% quarter-over-quarter.
  • 10 funds opened new TuHURA Biosciences positions in Q1 2021 and 4 closed out, a net change of +6 holders.
  • The largest TuHURA Biosciences buyer in Q1 2021 was Nantahala Capital Management, an estimated $1.22M added.
  • The largest TuHURA Biosciences seller in Q1 2021 was Two Sigma Investments, an estimated $22K sold.

Based on aggregated 13F filings for Q1 2021.